NCT04141228View on ClinicalTrials.gov

A Study of Hospital Healthcare Use and Cost in Patients in the Hospital With a Venous Thromboembolism (VTE) Treated With Apixaban or Warfarin in the US

CompletedOBSERVATIONAL
Enrollment

28,000

Participants

Timeline

Start Date

November 29, 2016

Primary Completion Date

April 30, 2018

Study Completion Date

May 31, 2018

Conditions
Venous Thromboembolism (VTE)
Trial Locations (1)

08822

Local Institution, Flemington

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY